Evidence map›Paper›PMID 32021624›Full record

ReviewIranian journal of child neurology2020

Bilirubin Induced Encephalopathy.

Parvaneh Karimzadeh, Minoo Fallahi, Mohammad Kazemian, Naeeme Taslimi Taleghani, Shamsollah Nouripour, Mitra Radfar

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Iranian journal of child neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05566548 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Importance of Bilirubin Molecular Species in Patients With Liver Cirrhosis Who Develop Hepatic Encephalopathy and Patients With Acute-on-chronic Liver Failure

TypeobservationalSponsorMedica Sur Clinic & FoundationRan2022 to 2023Enrolled50ConditionsHepatic Encephalopathy, Acute-On-Chronic Liver FailureArmsLiquid Chromatography-Mass Spectrometry Method to identify bilirubin molecular species
NCT06603753 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Use of Serum Bilirubin/Albumin Ratio for Early Prediction of Bilirubin Induced Neurological Dysfunction

TypeobservationalSponsoralaa aboelhassan mohamed aboelhassanRan2025 to 2026Enrolled80ConditionsHyperbilirubinemia, Neonatal
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Parvaneh KarimzadehPediatric Neurology Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Minoo FallahiNeonatal Health Research Center Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad KazemianNeonatal Health Research Center Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Naeeme Taslimi TaleghaniShahid Beheshti University of Medical Sciences, Mahdieh Hospital, Tehran, Iran.
Shamsollah NouripourNeonatal Health Research Center Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mitra RadfarShahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran.
Shahid Beheshti University of Medical Sciences · IRImam Hossein Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperbilirubinemia is one of the most common neonatal disorders. Delayed diagnosis and treatment of the pathologic and progressive indirect hyperbilirubinemia lead to neurological deficits, defined as bilirubin induced encephalopathy (BIE) (2). The incidence of this disorder in underdeveloped countries is much more than developed areas. All neonates with the risk factors for increased the blood level of indirect bilirubin are at risk for BIE, especially preterm neonates which are prone to low bilirubin kernicterus . BIE can be transient and acute (with early, intermediate and advanced phases)or be permanent, chronic and lifelong ( with tetrad of symptoms including visual (upward gaze palsy), auditory (sensory neural hearing loss), dental dysplasia abnormalities, and extrapyramidal disturbances (choreoathetosis cerebral palsy).Beside the abnormal neurologic manifestations of the jaundiced neonates ,brain MRI is the best imaging modality for the confirmation of the diagnosis. Although early treatment of extreme hyperbilirubinemia by phototherapy and exchange transfusion can prevent the BIE, unfortunately the chronic bilirubin encephalopathy does not have definitive treatment.

Indexed as

Bilirubin Induced EncephalopathyKernicterusNeonatal Jaundice

Identifiers

PMID32021624
PMCPMC6956966
OpenAlexW3013465505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.